Skip to main content
Log in

Absence of severe tardive dyskinesia in hungarian schizophrenic out-patients

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

One hundred and twenty-two patients comprising 82% of the non-hospitalized schizophrenic population of a Hungarian town were rated for tardive dyskinesia (TD). Drug histories were also obtained. No severe cases of TD were found. The markedly lower prevalence of TD in the study population in contrast to similar North American samples may be related to differences in treatment styles, in particular to: a) use of EST in place of high-dose neuroleptic therapy; b) extensive exposure to ethopropazine, promethazine, and other antiparkinson drugs. Twenty patients revealed clinically evident fine tremors, mostly of the tongue and eye-lid. Multivariate analysis revealed a positive association of choreiform dyskinesia with duration of low-potency neuroleptic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Asnis GM, Leopold MA, Duvoisin RC, schwartz AR (1977) A survey of tardive dyskinesia in psychiatric outpatients. Am J Psychiatry 134:1367–1370

    Google Scholar 

  • Chouinard G, Annable S, Ross-Chouinard A, Nestoros JN (1979a) Factors related to tardive dyskinesia. Am J Psychiatry 136:79–83

    Google Scholar 

  • Chouinard G, Annable L, Ross-Chouinard A, Kropsky ML (1979b) Ethopropazine and benztropine in neuroleptic-induced Parkinsonism. J Clin Psychiatry 40:73–81

    Google Scholar 

  • Crane GE (1968) Dyskinesia and neuroleptics. Arch Gen Psychiatry 19:700–703

    Google Scholar 

  • DiMascio A, Demirgian E (1970) Antiparkinson drug overuse. Psychosomatics 11:596–601

    Google Scholar 

  • Ezrin-Waters C, Seeman MV, Seeman P (1979) Prevalence of tardive dyskinesia in schizophrenic outpatients. Presented at the Royal Society of Canada, Montreal

  • Gardos G, Cole JO, LaBrie RA (1977) Drug variables in the etiology of tardive dyskinesia. Prog Neuropsychopharmacol 1:147–154

    Google Scholar 

  • Gibson AC (1978) Depot injections and tardive dyskinesia. Br J Psychiatry 132:361–365

    Google Scholar 

  • Guy W (1976) ECDEU assessment manual for psychopharmacology, DHEW publication No. 76-338. U.S. Government Printing Office, Washington, D.C., pp 534–537

    Google Scholar 

  • Menken M, Safer J, Goldfarb C, Varga E (1979) Multiple ECT: Morphologic effects. Am. J Psychiatry 136:p 453

    Google Scholar 

  • Ogita K, Yagi G, Itoh H, Miura S, Lambert P-A (1975) Comparative analysis of persistent dyskinesias of long-term usage with neuroleptics in France and Japan. Folia Psychiatr Neurol Jpn 29:315–320

    Google Scholar 

  • Price TRP, Lewin R (1978) The effects of electroconvulsive therapy on tardive dyskinesia. Am J Psychiatry 135:991–993

    Google Scholar 

  • Simpson G, Lee JH, Zoubok B, Gardos G (1979) A rating scale for tardive dyskinesia. Psychopharmacology 64:171–179

    Google Scholar 

  • Smith JM, Kucharski LT, Eblen C, Knutzen E, Linn C (1979a) An assessment of tardive dyskinesia in schizophrenic out-patients. Psychopharmacology 64:99–104

    Google Scholar 

  • Smith JM, Kucharski LT, Oswald WT, Waterman LJ (1979b) A systematic investigation of tardive dyskinesia in in-patients. Am J Psychiatry 136:918–922

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardos, G., Samu, I., Kallos, M. et al. Absence of severe tardive dyskinesia in hungarian schizophrenic out-patients. Psychopharmacology 71, 29–34 (1980). https://doi.org/10.1007/BF00433248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00433248

Key words

Navigation